128 related articles for article (PubMed ID: 11020348)
1. Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo.
Gerdes CA; Castro MG; Löwenstein PR
Mol Ther; 2000 Oct; 2(4):330-8. PubMed ID: 11020348
[TBL] [Abstract][Full Text] [Related]
2. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area.
Kügler S; Kilic E; Bähr M
Gene Ther; 2003 Feb; 10(4):337-47. PubMed ID: 12595892
[TBL] [Abstract][Full Text] [Related]
3. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain.
Thomas CE; Birkett D; Anozie I; Castro MG; Lowenstein PR
Mol Ther; 2001 Jan; 3(1):36-46. PubMed ID: 11162309
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
5. Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoter.
Navarro V; Millecamps S; Geoffroy MC; Robert JJ; Valin A; Mallet J; Gal La Salle GL
Gene Ther; 1999 Nov; 6(11):1884-92. PubMed ID: 10602384
[TBL] [Abstract][Full Text] [Related]
6. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors.
Doll RF; Crandall JE; Dyer CA; Aucoin JM; Smith FI
Gene Ther; 1996 May; 3(5):437-47. PubMed ID: 9156805
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
8. Modifications in adenoviral coat fiber proteins and transcriptional regulatory sequences enhance transgene expression.
Perlman H; Liu H; Georganas C; Woods JM; Amin MA; Koch AE; Wickham T; Kovesdi I; Mano T; Walsh K; Pope RM
J Rheumatol; 2002 Aug; 29(8):1593-600. PubMed ID: 12180715
[TBL] [Abstract][Full Text] [Related]
9. Long-term retinal transgene expression with FIV versus adenoviral vectors.
Loewen N; Leske DA; Cameron JD; Chen Y; Whitwam T; Simari RD; Teo WL; Fautsch MP; Poeschla EM; Holmes JM
Mol Vis; 2004 Apr; 10():272-80. PubMed ID: 15094709
[TBL] [Abstract][Full Text] [Related]
10. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements.
de Leeuw B; Su M; ter Horst M; Iwata S; Rodijk M; Hoeben RC; Messing A; Smitt PS; Brenner M
J Neurosci Res; 2006 Apr; 83(5):744-53. PubMed ID: 16496373
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene transfer into rat livers: comparative study of retrograde intrabiliary and antegrade intraportal administration.
Kuriyama S; Yoshiji H; Nakai S; Deguchi A; Uchida N; Kimura Y; Inoue H; Kinekawa F; Ogawa M; Nonomura T; Masaki T; Kurokohchi K; Watanabe S
Oncol Rep; 2005 Jan; 13(1):69-74. PubMed ID: 15583804
[TBL] [Abstract][Full Text] [Related]
12. Muscle derived cell mediated ex vivo gene transfer to the lower urinary tract: comparison of viral vectors.
Pruchnic R; Yokoyama T; Lee JY; Huard J; Chancellor MB
Urol Res; 2002 Oct; 30(5):310-6. PubMed ID: 12389119
[TBL] [Abstract][Full Text] [Related]
13. Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats.
Kumai Y; Ooboshi H; Kitazono T; Takada J; Ibayashi S; Fujishima M; Iida M
Exp Neurol; 2003 Dec; 184(2):904-11. PubMed ID: 14769382
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral-mediated skeletal muscle transcriptional targeting using chimeric tissue-specific promoters.
Frauli M; Ribault S; Neuville P; Augé F; Calenda V
Med Sci Monit; 2003 Feb; 9(2):BR78-84. PubMed ID: 12601283
[TBL] [Abstract][Full Text] [Related]
15. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
Sung RS; Qin L; Bromberg JS
Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
[TBL] [Abstract][Full Text] [Related]
16. Differential influence of the E4 adenoviral genes on viral and cellular promoters.
Grave L; Dreyer D; Dieterle A; Leroy P; Michou AI; Doderer C; Pavirani A; Lusky M; Mehtali M
J Gene Med; 2000; 2(6):433-43. PubMed ID: 11199264
[TBL] [Abstract][Full Text] [Related]
17. Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter.
Wang CY; Wang S
Gene Ther; 2006 Oct; 13(20):1447-56. PubMed ID: 16724097
[TBL] [Abstract][Full Text] [Related]
18. Targeted transgene expression in rat brain using lentiviral vectors.
Jakobsson J; Ericson C; Jansson M; Björk E; Lundberg C
J Neurosci Res; 2003 Sep; 73(6):876-85. PubMed ID: 12949915
[TBL] [Abstract][Full Text] [Related]
19. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
